Stericycle (NASDAQ: SRCL) is one of 20 publicly-traded companies in the “Waste Management, Disposal & Recycling Services” industry, but how does it compare to its competitors? We will compare Stericycle to similar businesses based on the strength of its profitability, earnings, dividends, institutional ownership, valuation, analyst recommendations and risk.
This table compares Stericycle and its competitors’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Risk and Volatility
Stericycle has a beta of 0.16, meaning that its share price is 84% less volatile than the S&P 500. Comparatively, Stericycle’s competitors have a beta of 0.71, meaning that their average share price is 29% less volatile than the S&P 500.
This is a breakdown of current ratings and recommmendations for Stericycle and its competitors, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Stericycle currently has a consensus target price of $75.90, indicating a potential upside of 12.78%. As a group, “Waste Management, Disposal & Recycling Services” companies have a potential upside of 10.13%. Given Stericycle’s higher possible upside, research analysts plainly believe Stericycle is more favorable than its competitors.
Valuation and Earnings
This table compares Stericycle and its competitors gross revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|Stericycle||$3.56 billion||$206.35 million||-118.07|
|Stericycle Competitors||$850.65 million||$28.19 million||146.92|
Stericycle has higher revenue and earnings than its competitors. Stericycle is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.
Insider and Institutional Ownership
94.6% of Stericycle shares are owned by institutional investors. Comparatively, 52.9% of shares of all “Waste Management, Disposal & Recycling Services” companies are owned by institutional investors. 3.5% of Stericycle shares are owned by company insiders. Comparatively, 12.3% of shares of all “Waste Management, Disposal & Recycling Services” companies are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Stericycle beats its competitors on 7 of the 13 factors compared.
Stericycle Company Profile
Stericycle, Inc. is a business-to-business services provider. The Company focuses on regulated and compliance solutions for healthcare, retail, and commercial businesses. The Company’s segments include Domestic and Canada Regulated Waste and Compliance Services (RCS), Domestic Communication and Related Services (CRS), International RCS and All other. The Domestic and Canada RCS and International RCS segments include medical waste disposal, pharmaceutical waste disposal, hazardous waste management, sustainability solutions for expired or unused inventory, secure information destruction of documents and e-media, training and consulting through its Steri-Safe and Clinical Services programs, and other regulatory compliance services. The Domestic CRS segment consists of inbound/outbound communication, automated patient reminders, online scheduling, notifications, product retrievals, product returns and quality audits.
Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with MarketBeat.com's FREE daily email newsletter.